Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team of radiologists and radiographers at Oxford University Hospitals and University of Oxford's Department of Oncology has secured a grant to customise a teaching platform to educate frontline NHS staff to diagnose COVID-19 using chest X-rays and CT scans.

Chest x-ray from taken by radiographers at Oxford University Hospitals

Dr Sarim Ather, a Specialist Registrar in Clinical Radiology, has been working alongside Professor Fergus Gleeson (Department of Oncology), Dr Rachel Benamore, Dr Andrew Murchinson and Julie-Ann Moreland to develop the Report and Image Quality Control (RAIQC) training platform. This interactive web-based platform hosts a large database of diagnostic quality images and other educational materials that allow clinical staff to assess in real time their medical image reporting skills.

Now they have won funding from the pharmaceutical company Pfizer to develop additional material for the platform, to help frontline clinicians to recognise COVID-19 on patients' chest X-rays and CT scans, as well as other life-threatening conditions with which the COVID-19 images can be confused.

The Oxford-based Interactive Pharma Solutions, who have been carrying out the technical development of the RAIQC platform, provided pro-bono support to help create the COVID-19 module.

Read the full story on the Oxford University Hospitals (OUH) website

Similar stories

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.